TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Prevalence of coronary vasomotor dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Copy Number Variations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nociception Coma Scale-Revised
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in tumor vascular (blood flow, blood volume)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Epidemiology of fungemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: HIV RNA level (Viral Load)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Injection-associated adverse events or serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Neutralizing antibody titers to SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS)
Endpoint domain: Mortality/survival
Primary endpoint: Change in the overall IBS Severity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of air leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Bleeding episode
Endpoint domain: Adverse events/effects
Primary endpoint: urinary excretion of BIA 5-453 associated radioactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: faecal excretion of BIA 5-453 associated radioactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: amount of BIA 5-453 associated radioactivity present in the expired air
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Medical Hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Emergency Care visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Primary care utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants With Any Clinically Relevant Urinalysis Parameter Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Participants With Clinically Significant Electrocardiogram Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Aesthetic burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Duration of Agitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICU inpatient mortality
Endpoint domain: Mortality/survival
Primary endpoint: ICU inpatient length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Existence of CRPS
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Adverse events including serious Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Food effect as assessed by PK parameters including AUC and Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of documented alarm symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients diagnosed with cancer
Endpoint domain: Mortality/survival
Primary endpoint: changes in BNA™ measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of completion of the LP with VR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Change of Hippocampal Volume Slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Eye Comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under the curve (AUC) of plasma glucose level after breakfast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: motor symptoms change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: non-motor symptoms change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleep quality change
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: daytime sleepiness change
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: signs of depression change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in maximum aerobic capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 24-hour systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Microbiologic cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score in Subjective Well-being under Neuroleptic treatment (SWN-K)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total score in Calgary Depression Rating Scale (CDRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CMV Cell-Mediated Immune Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total iv morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of continuity/discontinuity of child care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Number of Patients With a PSA Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: RECIST-defined Measurable Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Correlation between study questionnaire answers and patient demographics
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Correlation between study questionnaire answers and time required by pharmacokinetic sampling
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Correlation between study questionnaire answers and the need for additional IV
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: COX-2 Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: APC Protein Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: β-catenin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathogen colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Postprandial Lipemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Investigator Assessed Improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cervical disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Motor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Self-Regulation Processes towards Healthy Eating
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change of Students' Attitudes and Perceptions on Healthy Eating
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change of Knowledge of Healthy Eating
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: International Falls Effectiveness Scale (FES-I)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Unified Parkinson Disease Rating Scale - Session II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants Surviving With Viral Suppression
Endpoint domain: Mortality/survival
Primary endpoint: Participants With Treatment Emergent Adverse Events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Response to chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Increase in Plasma Glucose Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cotinine-validated 7-day point prevalence tobacco abstinence at 1 year follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cotinine-validated 7-day point prevalence tobacco abstinence at 3 month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body composition (truncal fat and visceral fat)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: muscle mass and strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Detection of pancreas cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: FLACC Behavioral Pain Assessment Scale Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6 month progression-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Decreased symptoms of posttraumatic stress disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased symptoms of comorbid conditions of depression and alcohol dependence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of intensive care treatment
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Duration of postoperative ventilation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Well-being measured in UPDRS III
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Well-being measured in H&Y scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: spherical equivalent progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: axial length change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Local Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: change in asthma symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Response rate to chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in low back pain (NPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful repositioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with severe toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: 8-week non progression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Brief Resiliency Scale (BRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: plasma atovaquone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma proguanil concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma cycloguanil concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of death, MI, stroke or non CABG major bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Number of immune cells in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Transcriptome profiles of immune cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Transplant Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Sensitivity of multiplex ELISA kit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of multiplex ELISA kit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Help Seeking Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of exosome-based liquid biopsy signature levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective mandibular length (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mandibular plane angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maxillary incisors inclination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mandibular incisors inclination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in Total Nasal Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cell phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Overall Survival (OS) at 1 Year
Endpoint domain: Mortality/survival
Primary endpoint: Progressive Free Survival (PFS) after 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Amplitude of immunohistochemical stain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cervical Ripening Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: change in visceral, subcutaneous, total fat area and ratio of visceral and subcutaneous fat area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: The Purdue Pegboard Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Subjects Who Exhibit an HE Episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical regression of actinic keratoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Histopathologic regression of actinic keratoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prevalence of celiac serology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Driving Performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Additive clinical diagnostic value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of childhood injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Hypothalamic Pituitary Adrenal Axis Function Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Postoperative stay in days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total number of Objective Responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of hepatic fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in IgG4-RD Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Aortic pressure waveform characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Amount of Postoperative Bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Concordance between urinary test results and beta-hCG blood measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Need of Labor Induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Duration of delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Language Task ERP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Language Task Alpha Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Comfort Averaged Over All Follow-up Visits
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dryness Averaged Over All Follow-up Visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Eyes With Slit Lamp Findings Greater Than Grade 2 at Any Follow-up Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postural stability score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with plasma HBV DNA levels below 116 copies/mL at Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with plasma HBV DNA levels below 116 copies/mL at Week 96
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurodevelopmental outcome at age 2 years
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Behavior in Physicians Attitude Towards a Decision to Give a Medication
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Time to first AF recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Death occurring within 90-days of the last NEWS measurement
Endpoint domain: Mortality/survival
Primary endpoint: Death occurring within one day after the first NEWS measurement on general wards
Endpoint domain: Mortality/survival
Primary endpoint: Change in Number of Cigarettes Smoked Per Day (CPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Exhaled Carbon Monoxide (CO) Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak estimated blood alcohol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Meibomian gland assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility as Measured by Number of Recruited Eligible Patients Enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability as Measured by Number of Participants Who Completed the Study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of days covered with medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Weekly mean of average daily pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Solicited Local Adverse Events (AEs) Post Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Solicited Systemic Adverse Events (AEs) Post Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Serious Adverse Events (SAEs) Post Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Change From Baseline in Hemoglobin A1c (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Immediate Reactions Occurring Within 60 Minutes of Administration of Any Dose
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With at Least One Solicited Reactogenicity After Both Injections
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With at Least One Unsolicited AE
Endpoint domain: Adverse events/effects
Primary endpoint: All Serious Adverse Events (SAEs) Occurring Within 3 Weeks of Receipt of Any Dose
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Ventilator Free Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence Rate of Hospitalization or ED Visit for COPD Exacerbation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Area under the concentration versus time curve (AUC[0-inf])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration (AUC[0-tlast])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observed time of maximum concentration (tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of urinary catheters
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knee Injury and Osteoarthritis Outcome Joint Replacement Survey (KOOS) Jr 7-item score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SP/AP ratio of electrocochleography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: threshold tuning curve of cVEMP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: threshold tuning curve of oVEMP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: nursing home admission rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Objective recurrent rate
Endpoint domain: Mortality/survival
Primary endpoint: Impact of fibromyalgia on daily quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Extent of Sexualization
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Extent of Physical Attractiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Extent of Positive Body Image
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SAF Activity Score (SAF-A) Decrease of at Least 2 Points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No Worsening of the CRN Fibrosis Score (CRN-F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PaO2 difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: A-a O2 difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of Feeding Assistance Care Processes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use